Notice for changes or additional information
Legal Basis:
Regulation (EU, Euratom) No 2018/1046
Section I: Contracting authority/entity
I.1)Name and addressesOfficial name: European Health and Digital Executive Agency (HaDEA), HADEA.A – Health and Food
Postal address: COV2, Place Charles Rogier 16
Town: Brussels
NUTS code:
BE100 Arr. de Bruxelles-Capitale / Arr. Brussel-HoofdstadPostal code: 1210
Country: Belgium
E-mail:
HADEA-HP-TENDER@ec.europa.euInternet address(es): Main address:
https://hadea.ec.europa.eu Section II: Object
II.1)Scope of the procurement
II.1.1)Title:
Feasibility Study, Design and Prototype Development for a Mapping Platform on COVID-19 Therapeutics in the EU
Reference number: HADEA/2021/OP/0009
II.1.2)Main CPV code73000000 Research and development services and related consultancy services
II.1.3)Type of contractServices
II.1.4)Short description:
Service contract encompassing the feasibility assessment, the design and prototype development of an interactive platform mapping the production capacity and supply of COVID-19 therapeutics in the EU including products in research and development phases. Such therapeutics can include ICU medicines, heparin, dexamethasone and antibiotics, in vitro diagnostics devices/companion diagnostics.
Section VI: Complementary information
VI.5)Date of dispatch of this notice:17/10/2021
VI.6)Original notice reference Section VII: Changes
VII.1)Information to be changed or added
VII.1.2)Text to be corrected in the original noticeSection number: IV.2.2)
Place of text to be modified: Time limit for receipt of tenders or requests to participate
Instead of:
Date: 29/10/2021
Local time: 16:00
Read:
Date: 12/11/2021
Local time: 16:00
Section number: IV.2.7)
Place of text to be modified: Conditions for opening of tenders
Instead of:
Date: 04/11/2021
Local time: 16:00
Read:
Date: 16/11/2021
Local time: 12:00
VII.2)Other additional information: